Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

327 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Id2 is dispensable for myc-induced lymphomagenesis.
Nilsson JA, Nilsson LM, Keller U, Yokota Y, Boyd K, Cleveland JL. Nilsson JA, et al. Among authors: nilsson lm. Cancer Res. 2004 Oct 15;64(20):7296-301. doi: 10.1158/0008-5472.CAN-04-2133. Cancer Res. 2004. PMID: 15492249
BET and HDAC inhibitors induce similar genes and biological effects and synergize to kill in Myc-induced murine lymphoma.
Bhadury J, Nilsson LM, Muralidharan SV, Green LC, Li Z, Gesner EM, Hansen HC, Keller UB, McLure KG, Nilsson JA. Bhadury J, et al. Among authors: nilsson ja, nilsson lm. Proc Natl Acad Sci U S A. 2014 Jul 1;111(26):E2721-30. doi: 10.1073/pnas.1406722111. Epub 2014 Jun 16. Proc Natl Acad Sci U S A. 2014. PMID: 24979794 Free PMC article.
Myc-induced SUMOylation is a therapeutic vulnerability for B-cell lymphoma.
Hoellein A, Fallahi M, Schoeffmann S, Steidle S, Schaub FX, Rudelius M, Laitinen I, Nilsson L, Goga A, Peschel C, Nilsson JA, Cleveland JL, Keller U. Hoellein A, et al. Among authors: nilsson ja, nilsson l. Blood. 2014 Sep 25;124(13):2081-90. doi: 10.1182/blood-2014-06-584524. Epub 2014 Aug 20. Blood. 2014. PMID: 25143484 Free PMC article.
Melanoma patient-derived xenografts accurately model the disease and develop fast enough to guide treatment decisions.
Einarsdottir BO, Bagge RO, Bhadury J, Jespersen H, Mattsson J, Nilsson LM, Truvé K, López MD, Naredi P, Nilsson O, Stierner U, Ny L, Nilsson JA. Einarsdottir BO, et al. Among authors: nilsson ja, nilsson o, nilsson lm. Oncotarget. 2014 Oct 30;5(20):9609-18. doi: 10.18632/oncotarget.2445. Oncotarget. 2014. PMID: 25228592 Free PMC article.
327 results